Companies Dominating the Intraocular Lens Injectors Landscape
- SpyGlass Pharma
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Alcon
- Bausch Health Companies, Inc.
- Carl Zeiss AG
- Johnson & Johnson Services, Inc.
- The Cooper Companies, Inc.
- EssilorLuxottica
- Ziemer Ophthalmic Systems AG
- Staar Surgical
- Haag-Streit AG
The intraocular lens injectors market consists of a number of key players. These key players are launching various strategic initiatives to expand their market position in the intraocular lens injectors industry.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of intraocular lens injectors is assessed at USD 17.16 billion.
The intraocular lens injectors market size was over USD 16.43 billion in 2024 and is projected to reach USD 31.76 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by growing prevalence of cataracts.
North America industry is poised to account for largest revenue share of 30% by 2037, influenced by growing prevalence ophthalmic disorders in the region.
The major players in the market are SpyGlass Pharma, Alcon, Bausch Health Companies, Inc., Carl Zeiss AG, and others.
